UsAgainstAlzheimer's is requesting organizational endorsements for the CHANGE Act (Concentrating on High-Value Alzheimer’s Needs to Get to an End (CHANGE) Act of 2019) that will be introduced by Sens. Shelley Moore Capito (R-WV), Debbie Stabenow (D-MI), and Roger Wicker (R-MS) and Reps. Darren Lahood (R-IL), Doris Matsui (D-CA), and Linda Sanchez (D-CA). The CHANGE Act is bipartisan and bicameral legislation that encourages early detection, treatment, and access to care for families touched by Alzheimer's
Bill Provisions
●Detection and Treatment: Directs the Centers for Medicare and Medicaid Services to require use of cognitive impairment detection tool or set of tools identified by the National Institutes of Health. Use of these tools will incentivize clinicians to detect and diagnose Alzheimer’s and related dementias in their earliest stages. If cognitive impairment is detected, patients are to be referred for additional testing, to community-based support services, and to appropriate clinical trials.
●Access to Care: Requires the Centers of Medicare and Medicaid Services to lead, create, adopt, and recognize quality measures and incentives to promote the detection and diagnosis of Alzheimer’s disease or related dementias and appropriate care planning services, including potential for clinical trial participation.
One Pager on CHANGE Act:
https://www.dropbox.com/s/2ohu2gctx5osd9o/CHANGE%20ACT%20OF%202019%20Bill%20Summary%20FINAL.pdf?dl=0